| Ident. | Authors (with country if any) | Title |
|---|
| 000024 (2015) |
Raphael Carapito [France] ; Nicodème Paul ; Meiggie Untrau ; Marion Le Gentil ; Louise Ott ; Ghada Alsaleh ; Pierre Jochem ; Mirjana Radosavljevic ; Cédric Le Caignec ; Albert David ; Philippe Damier ; Bertrand Isidor ; Seiamak Bahram | A de novo ADCY5 mutation causes early-onset autosomal dominant chorea and dystonia. |
| 000046 (2014) |
Kathy Dujardin [France] ; Carole Langlois ; Lucie Plomhause ; Anne-Sophie Carette ; Marie Delliaux ; Alain Duhamel ; Luc Defebvre [France] | Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms. |
| 000083 (2013) |
Claude Vital [France] ; Anne Vital | Are substantia nigra neurons subject to mitochondrial dysfunction in early life more able to adapt? |
| 000116 (2012) |
Christina Meyer [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; Carsten Schwenke [Allemagne] ; Adam Doble [France] ; Michael Orth [Allemagne] ; Albert C. Ludolph [Allemagne] | Rate of Change in Early Huntington's Disease: a Clinicometric Analysis |
| 000132 (2012) |
Fanny Mochel [France] ; Tra-My N'Guyen [France] ; Dinesh Deelchand [États-Unis] ; Daisy Rinaldi [France] ; Romain Valabregue [France] ; Claire Wary [France] ; Pierre G. Carlier [France] ; Alexandra Durr [France] ; Pierre-Gilles Henry [États-Unis] | Abnormal Response to Cortical Activation in Early Stages of Huntington Disease |
| 000157 (2011) |
Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas] | Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials |
| 000176 (2011) |
Andreas Kupsch [Allemagne] ; Michele Tagliati [États-Unis] ; Marie Vidailhet [France] ; Tipu Aziz [Royaume-Uni] ; Paul Krack [France] ; Elena Moro [Canada] ; Joachim K. Krauss [Allemagne] | Early postoperative management of DBS in dystonia: Programming, response to stimulation, adverse events, medication changes, evaluations, and troubleshooting |
| 000200 (2010) |
Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche] | Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease |
| 000217 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000219 (2010) |
Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas] | Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease |
| 000250 (2009) |
Nathalie Chastan [France] ; Jacques Weber [France] | Infraclinical postural instability in early‐stage Parkinson's disease? |
| 000291 (2008) |
Christoph Globas [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laslo Baliko [Hongrie] ; Syliva Boesch [Autriche] ; Chantal Depondt [Belgique] ; Stefano Didonato [Italie] ; Alexandra Durr [France] ; Alessandro Filla [Italie] ; Thomas Klockgether [Allemagne] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Pascale Ribai [France] ; Rafal Rola [Pologne] ; Tanja Schmitz-Hubsch [Allemagne] ; Sandra Szymanski [Allemagne] ; Dagmar Timmann [Allemagne] ; Bart P. Van De Warrenburg [Pays-Bas] ; Peter Bauer [Allemagne] ; Ludger Schols [Allemagne] | Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6 |
| 000292 (2008) |
Mathieu Anheim [France] ; Laurent Vercueil [France] ; Valerie Fraix [France] ; Stéphan Chabardès [France] ; Eric Seigneuret [France] ; Paul Krack [France] ; Alim-Louis Benabid [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] | Early stimulation of DYT1 primary generalized dystonia prevents from its secondary irreversible complications |
| 000293 (2008) |
Agnès Annic [France] ; David Devos [France] ; Alain Destée [France] ; Luc Defebvre [France] ; Arnaud Lacour [France] ; Jean-François Hurtevent [France] ; Tanya Stojkovic [France] | Early dopasensitive Parkinsonism related to myotonic dystrophy type 2 |
| 000295 (2008) |
Nathalie Chastan [France] ; Bertrand Debono [France] ; David Maltête [France] ; Jacques Weber [France] | Discordance between measured postural instability and absence of clinical symptoms in Parkinson's disease patients in the early stages of the disease |
| 000322 (2007) |
Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis] | Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease |
| 000353 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
| 000357 (2006) |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 000369 (2006) |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000384 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
| 000455 (2003) |
Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
